Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
1.370
-0.030 (-2.14%)
Feb 21, 2025, 4:00 PM EST - Market closed
Vor Biopharma Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$11.36
Upside
+729.20%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +1,177.37% | Dec 10, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $12 | Buy | Reiterates | $12 | +775.91% | Dec 10, 2024 |
| Baird | Baird | Buy Maintains $22 → $14 | Buy | Maintains | $22 → $14 | +921.90% | Nov 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +1,177.37% | Nov 8, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $12 | Buy | Reiterates | $12 | +775.91% | Sep 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +1,177.37% | Sep 6, 2024 |
| Barclays | Barclays | Buy Maintains $10 → $3 | Buy | Maintains | $10 → $3 | +118.98% | Aug 14, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $12 | Buy | Reiterates | $12 | +775.91% | May 13, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $15 → $10 | Buy | Reiterates | $15 → $10 | +629.93% | May 13, 2024 |
| Wedbush | Wedbush | Buy Reiterates $11 | Buy | Reiterates | $11 | +702.92% | May 10, 2024 |
| Wedbush | Wedbush | Buy Reiterates $11 | Buy | Reiterates | $11 | +702.92% | Apr 23, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $12 | Buy | Reiterates | $12 | +775.91% | Mar 22, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +1,177.37% | Mar 21, 2024 |
| Wedbush | Wedbush | Buy Reiterates $11 | Buy | Reiterates | $11 | +702.92% | Mar 21, 2024 |
| Stifel | Stifel | Strong Buy Maintains $15 → $12 | Strong Buy | Maintains | $15 → $12 | +775.91% | Mar 21, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $17 → $15 | Buy | Reiterates | $17 → $15 | +994.89% | Mar 21, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.